Plenary Session

385 Folgen

1. 1.25 Welch's Legacy, Interpreting NGS, Uncertainty over Pregabalin, Beyond EBM with Dr. Sam Edwards

   Vom: 27.11.2018
2. 1.24 Useless Medical Conferences and Dr. Adam Obley on Vascepa, Fish Oil, Vitamin D and Methotrexate

   Vom: 20.11.2018
3. 1.23 BONUS! Developing Technology with Fewer Reversals: Maybe We Need More Translation Failure

   Vom: 15.11.2018
4. 1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner

   Vom: 13.11.2018
5. 1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees

   Vom: 6.11.2018
6. 1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross

   Vom: 30.10.2018
7. 1.19 BONUS! Introduction to Cancer Drug Policy

   Vom: 26.10.2018
8. 1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan

   Vom: 23.10.2018
9. 1.17 BONUS! Interpretation of Cancer Clinical Trials

   Vom: 22.10.2018
10. 1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong

    Vom: 17.10.2018
11. 1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare

    Vom: 16.10.2018
12. 1.14 BONUS! Immunotherapy in Desperation and the Pennington Lecture: Myths of Medicine and Marketing

    Vom: 12.10.2018
13. 1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu

    Vom: 8.10.2018
14. 1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology

    Vom: 3.10.2018
15. 1.11 Peanut Gallery, Research Parasites, Appendectomies, HRQoL and PFS, Dr. Bishal Gyawali

    Vom: 2.10.2018
16. 1.10 Criticism via Twitter, PACIFIC, PCI for CAD, and Dr. Rebecca Cooney of The Lancet

    Vom: 25.9.2018
17. 1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints

    Vom: 20.9.2018
18. 1.08 Hyperprolific authors, NCCN with Jeff Wagner, and Dr. Renee Dversdal on Ultrasounds

    Vom: 14.9.2018
19. 1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola

    Vom: 11.9.2018
20. 1.06 RELEVANCE, Jenny Gill, and Dr. Catherine Livingston of the Oregon Health Authority

    Vom: 7.9.2018